1. Activity of the oral mitogen‐activated protein kinase kinase inhibitor trametinib in RAS‐mutant relapsed or refractory myeloid malignancies. Issue 12 (18th March 2016) Authors: Borthakur, Gautam; Popplewell, Leslie; Boyiadzis, Michael; Foran, James; Platzbecker, Uwe; Vey, Norbert; Walter, Roland B.; Olin, Rebecca; Raza, Azra; Giagounidis, Aristoteles; Al‐Kali, Aref; Jabbour, Elias; Kadia, Tapan; Garcia‐Manero, Guillermo; Bauman, John W.; Wu, Yuehui; Liu, Yuan; Schramek,... Journal: Cancer Issue: Volume 122:Issue 12(2016) Page Start: 1871 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. AT‐101 downregulates BCL2 and MCL1 and potentiates the cytotoxic effects of lenalidomide and dexamethasone in preclinical models of multiple myeloma and Waldenström macroglobulinaemia. (17th November 2013) Authors: Paulus, Aneel; Chitta, Kasyapa; Akhtar, Sharoon; Personett, David; Miller, Kena C.; Thompson, Kevin J.; Carr, Jennifer; Kumar, Shaji; Roy, Vivek; Ansell, Stephen M.; Mikhael, Joseph R.; Dispenzieri, Angela; Reeder, Craig B.; Rivera, Candido E.; Foran, James; Chanan‐Khan, Asher Journal: British journal of haematology Issue: Volume 164:Number 3(2014:Feb.) Page Start: 352 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. BL‐8040 CXCR4 antagonist is safe and demonstrates antileukemic activity in combination with cytarabine for the treatment of relapsed/refractory acute myelogenous leukemia: An open‐label safety and efficacy phase 2a study. Issue 8 (3rd December 2020) Authors: Borthakur, Gautam; Ofran, Yishai; Tallman, Martin S.; Foran, James; Uy, Geoffrey L.; DiPersio, John F.; Showel, Margaret M.; Shimoni, Avichai; Nagler, Arnon; Rowe, Jacob M.; Altman, Jessica K.; Abraham, Michal; Peled, Amnon; Shaw, Stephen; Bohana‐Kashtan, Osnat; Sorani, Ella; Pereg, Yaron; Foley‐... Journal: Cancer Issue: Volume 127:Issue 8(2021) Page Start: 1246 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Clinical and molecular spectrum and prognostic outcomes of U2AF1 mutant clonal hematopoiesis- a prospective mayo clinic cohort study. (February 2023) Authors: Pritzl, Stephanie L.; Gurney, Mark; Badar, Talha; Ferrer, Alejandro; Lasho, Terra; Finke, Christy; Mangaonkar, Abhishek; McCullough, Kristen; Gangat, Naseema; Fernandez, Jenna; Al-Kali, Aref; Viswanatha, David; He, Rong; Foran, James; Patnaik, Mrinal M. Journal: Leukemia research Issue: Volume 125(2023) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Clinical utility of fluorescence in situ hybridization‐based diagnosis of BCR‐ABL1 like (Philadelphia chromosome like) B‐acute lymphoblastic leukemia. Issue 3 (26th January 2020) Authors: Anagnostou, Theodora; Knudson, Ryan A.; Pearce, Kathryn E.; Meyer, Reid G.; Pitel, Beth A.; Peterson, Jess F.; Baughn, Linda B.; Reichard, Kaaren K.; Ketterling, Rhett P.; Kloft‐Nelson, Sara M.; Knutson, Darlene L.; Khan, Shakila P.; Gangat, Naseema; Litzow, Mark R.; Hogan, William J.; Wolanskyj,... Journal: American journal of hematology Issue: Volume 95:Issue 3(2020:Mar.) Page Start: E68 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Current treatment preferences in chronic myeloid leukemia: The Mayo Clinic Physicians' survey. Issue 11 (17th August 2017) Authors: Begna, Kebede; Al‐Kali, Aref; Elliott, Michelle; Foran, James; Gangat, Naseema; Hogan, William; Hook, Christopher; Leis, Jose; Litzow, Mark; Mesa, Ruben; Palmer, Jeanne; Pardanani, Animesh; Patnaik, Mrinal; Rivera, Candido; Sproat, Lisa; Tibes, Raoul; Wolanskyj‐Spinner, Alexandra; Tefferi, Ayalew Journal: American journal of hematology Issue: Volume 92:Issue 11(2017:Nov.) Page Start: E626 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Efficacy of mitoxantrone-based salvage therapies in relapsed or refractory acute myeloid leukemia in the Mayo Clinic Cancer Center: Analysis of survival after 'CLAG-M' vs. 'MEC'. (March 2020) Authors: Scheckel, Caleb J; Meyer, Megan; Betcher, Jeffrey Alan; Al-Kali, Aref; Foran, James; Palmer, Jeanne Journal: Leukemia research Issue: Volume 90(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Epidemiology of adult acute myeloid leukemia: Impact of exposures on clinical phenotypes and outcomes after therapy. Issue 6 (December 2015) Authors: Finn, Laura; Sproat, Lisa; Heckman, Michael G.; Jiang, Liuyan; Diehl, Nancy N.; Ketterling, Rhett; Tibes, Raoul; Valdez, Ricardo; Foran, James Journal: Cancer epidemiology Issue: Volume 39:Issue 6(2015) Page Start: 1084 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Hairy cell leukemia with CCND1/IGH fusion gene and BRAF V600E mutation. (2020) Authors: Rahman, Zaid Abdel; Muwalla, Firas; Jiang, Liuyan; Foran, James Journal: Leukemia research reports Issue: Volume 13(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Impact of access to NCI‐ and NCCN‐designated cancer centers on outcomes for multiple myeloma patients: A SEER registry analysis. Issue 4 (13th November 2015) Authors: Ailawadhi, Sikander; Advani, Pooja; Yang, Dongyun; Ghosh, Radhika; Swaika, Abhisek; Roy, Vivek; Foran, James; Colon‐Otero, Gerardo; Chanan‐Khan, Asher Journal: Cancer Issue: Volume 122:Issue 4(2016) Page Start: 618 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗